The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

CBD and CBG, two non-intoxicating cannabis compounds, may help combat fatty liver disease by boosting liver energy reserves ...

FDA grants orphan drug status to orziloben for intestinal failure-associated liver disease (90)Orziloben secures FDA orphan ...

Resmetirom improved HRQOL versus placebo in early MASH, particularly abdominal symptoms, disease-related worry, and health distress, with onset by week 24 and durability through week 52. Baseline ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which is ...

Scientists have developed injectable "mini livers" that can replicate liver function, potentially buying time for those with liver disease.

Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Steatotic liver disease is an increasingly recognised comorbidity linked to HIV treatment.